Hemolytic Uremic Syndrome (HUS) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
Condition: Atypical Hemolytic-Uremic SyndromeIntervention: Drug: EculizumabSponsor: Alexion PharmaceuticalsCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2010 Category: Research Source Type: clinical trials

Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease
Condition: Atypical Hemolytic Uraemic Syndrome.Intervention: Sponsor: University Hospital, GhentRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2009 Category: Research Source Type: clinical trials

Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS
Condition: Atypical Hemolytic Uremic SyndromeIntervention: Drug: EculizumabSponsor: Alexion PharmaceuticalsCompleted - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2009 Category: Research Source Type: clinical trials

Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS
Condition: Atypical Hemolytic Uremic SyndromeIntervention: Drug: EculizumabSponsor: Alexion PharmaceuticalsCompleted - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2009 Category: Research Source Type: clinical trials